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Basis of Bone Metabolism around Dental Implants during Osseointegration and 
Peri-Implant Bone Loss 
 
 
Abstract 
Background: Despite the growing number of publications in the field of implant dentistry, there 
are limited studies to date investigating the biology and metabolism of bone healing around dental 
implants and their implications in peri-implant marginal bone loss. 
 
Purpose: The aim of this review article is to provide a thorough understanding of the biological 
events taking place during osseointegration and the subsequent early and late phases of bone 
remodeling around dental implants. An update on the coupling mechanism occurring during bone 
resorption-bone remodeling is provided, focused on the relevance of the osteocytes, bone lining 
cells and immune cells during bone maintenance.  
 
Material and methods: An electronic and manual literature search was conducted by three 
independent reviewers in several databases, including MEDLINE, EMBASE, Cochrane Central 
Register of Controlled Trials and Cochrane Oral Health Group Trials Register databases for 
articles up to September 2016 with no language restriction.  
 
Results: Local bone metabolism is subject to signals from systemic calcium-phosphate 
homeostasis and bone remodeling. Three areas of interest were reviewed due to recent reported 
compromises in bone healing including the putative effects of 1) cholesterol, 2) hyperlipidemia 
and 3) low vitamin D intake. Moreover, the prominent influence of osteocytes and immune cells 
is discussed as being key regulators during dental implant osseointegration and maintenance. 
These cells are of crucial importance in the presence of biofilm accumulation and their associated 
byproducts that leads to hard and soft tissue breakdown; the so called peri-implantitis. 
 
Conclusion: Factors that could negatively impact osteoclastogenesis or osteal macrophage 
activation should be monitored in future research including implant placement/torque protocols, 
bone characteristics, as well as meticulous maintenance programs to favor osseointegration and 
future long-term stability and success of dental implants. 
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Introduction 
Primary or mechanical stability in implant dentistry is regarded as a prerequisite for 
successful osseointegration. The alveolar bone architecture of the implant drilling site dictates the 
success of anchored endosseous implants. Immediately and up to several months afterwards, a 
series of cellular and molecular events take place where host tissues biologically integrate the 
alloplastic material into the native bony structure. While cortical bone has the function of 
withstanding torsional loading and provides higher initial stability, cancellous bone is richer in 
vascular canals and thus, vasculature to supply mesenchymal progenitor cells. In this sense, the 
complex and dynamic process of osseointegration may occur via contact osteogenesis, where the 
implant surface is populated by bone cells after fixation to form de novo bone, or via distance 
osteogenesis, where bone formation is preceded by the osteoclastogenesis of the existing tissue.
1
  
Nowadays, peri-implant disease does not represent an uncommon condition where, with 
no hesitation, plaque and its byproducts in a susceptible host are the primary etiology, as it has 
been demonstrated its cause-effect relationship.
2
 Moreover, certain risk factors/indicators such as 
smoking or history of periodontal disease have been strongly linked to the prevalence of peri-
implantitis. 
3, 4
 Nonetheless, other factors such as material biocompatibility, implant placement 
and material degradation / titanium particle release have been regarded as other potential factors 
associated with peri-implant bone loss as a prominent matter of discussion of its implication on 
osseointegration breakdown even in the lack of irritants.
5
 
Into the bargain, early peri-implant marginal bone loss was controversial due to limited 
knowledge on how hard tissue remodels as a consequence of the biological width adaptation. This 
has resulted in the development of novel modifications to the implant-abutment connections as 
well as an evolution towards hydrophilic and bioactive implant surfaces for early 
osseointegration. Nevertheless, a tight link between the osteogenic and osteoclastogenic pathways 
modulated by complement factor-3 signaling seems to play a further role on osteolysis led by 
monocytes/macrophages later discussed in this article. Moreover, the inflammatory response may 
be exacerbated by tissue trauma such as overheating or compression necrosis (i.e., high insertion 
toque). These might aggravate the peri-implant bone loss even in an aseptic environment, and 
worsen the implant prognosis due to the increased exposure of developing a later anaerobic 
infection, namely peri-implantitis.  Therefore, the aim of this narrative review is to provide an 
updated understanding of the biological events that take place during implant osseointegration 
and subsequent early and late bone remodeling around implants. 
 
1. Biology of the bone remodeling  
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1.1 Role of osteocytes and bone lining cells in the remodeling process 
Osteocytes are the pivotal cells in the regulation of bone mass and structure along with 
osteoblasts and osteoclasts.
6
 Osteoblasts are derived from mesemchymal stem cells and 
synthesize new bone matrix.
7
   Osteoclasts are terminally differentiated multinucleated cells from 
the monocyte-macrophage lineage and beyond their role in bone resorption, these cells are also a 
source of cytokines that play an important role in bone homeostasis. 
8
 
Osteocytes are terminally differentiated osteoblasts with a primary function to support 
bone structure and mechanosensation.
7
 They act as regulators of bone remodeling by modulating 
osteoclast and osteoblast activities. 
8
 These stellate-shapped cells are located within lacunae 
surrounded by mineralized bone matrix and present with connections through cytoplasmic 
prolongations with surface bone lining cells and also with bone marrow.
9
 
8
  
Bone lining cells (BLC) are cells involved in bone formation much like pre-osteoblasts, 
osteoblasts and osteocytes.
10
 They are characterized by a flat-shaped architecture along bony 
surfaces
8
 (Figure 1) and may be considered as latent osteoblasts.
11
 In human cancellous bone, 
around 65% of osteoblasts undergo apoptosis with approximately 30% differentiating into 
osteocytes,
12
 and the reduced remnants becoming BLC and chondroid-like cells.
10, 12
 BLCs 
maintain their proliferative capability and often differentiate into other osteogenic cells.
13, 14
 
Various studies have shown that some factors can induce their proliferation prior to bone 
formation,
15
 while mature osteolasts are unable to divide.
10
 Osteoblasts may also undergo a 
quiescent stage when there is no bone resorption or remodeling,
13
 but the function of BLCs might 
be more complex than a simple latent state,
16
 including catabolic and anabolic bone processes
15
 
and rapid bone formation under osteogenic signaling.
16
 
 
1. 2 Bone remodeling process 
As bone remodeling is a complex process previously discussed in various other 
excellent review articles1 17 and exceeds the limits of this review, we focus specifically on the 
pivotal implications of osteocytes and BLCs during this process (Figure 2 A). External factors 
such as mechanichal loading, irradiation, parathyroid hormone (PTH), fibroblast growth factor-2 
(FGF2), sclerostin inhibition or inflammation may lead BLCs to exit the quiescent stage into an 
active function phase by reforming cuboidal appearance and their secretory capability.
8, 15, 18
 The 
presence of BLCs observed histologically indicates a strong sign of osteogenic potential
13
 and 
often regarded as a major source of osteoblasts and proliferating pre-osteoblasts in the adult 
population.
15
 This prominent role in new bone formation was previously highlighted
12, 16
 when 
rapid bone formation after mechanical loading without previous bone resorption was observed. 
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Early peak of bone formation after three days was only possible if BLCs underwent reactivation 
and reaquired their secretory capacities.
12, 16
 
 
Moreover, BLCs exert a prominent function during bone resorption
19
 demonstrated by 
their ability to express key ostoclastogenesis markers including macrophage colony -stimulating 
factor receptor (M-CSFR) and  receptor activator of nuclear factor kappa-B ligand (RANKL).
15
  
BLCs have been shown to be in close contact with osteoclasts and may also modulate bone 
remodeling.
19
 These cells have been shown to digest the protrusive nonmineralized collagen 
fibers mediated by matrix metalloproteinases (MMPs) and clean the bone surface in order to 
facilitate osteoclast attachment to their surface and subsequent resorption process. Furthermore, 
the activation of BLCs after osteocyte apoptosis leads to the formation of the so-called bone 
remodeling compartment
17
 where osteoclasts resorb bone without damaging the surrounding 
environment. Later, the osteoprogenitor cells colonize these remaining surfaces left by 
osteoclastic cells.  
After the modulation of bone resorption, BLCs play another important role in the early 
stages of bone formation by entering the resorption lacunae to remove collagen fibers and debris 
left by osteoclasts (Figure 2B). Subsequentially to this cleaning function, BLCs secrete a layer of 
fibrillar collagen allowing osteoblasts to attach and deposit new osteoid.
19
 
 
1. 3 Loading and bone resorption 
Osteocytes and BLCs are part of a functional syncytium which regulates communication through 
gap junctions during their mechanoreceptive function.
6
 Based on finite element analysis/models, 
it has previously been shown that slight loading increases bone formation and inhibits 
resorption.
20, 21
 During this function, BLCs are remodeling activators
22
 and promote bone 
resorption unless an inhibitory signal from osteocytes is present.
23
 Bone formation by osteoblasts 
is downregulated by this inhibitory signal, proportional to the mechanical loading sensed by 
osteocytes.
23, 24
 Thus, an increase in bone remodeling may be observed when the strength of the 
inhibitory signal is low, triggered by a small generation signal or transmission failure. Bone 
disuse state without mechanical loading is an example of low strain-generated signal and the 
consequence is the activation of BLCs and bone loss. Transmission failure can be observed in 
cyclic loading, microdamage (microcracks) or difuse bone damage.
23
 Presence of microcracks or 
difuse damage may impair the intracellular and/or extracellular flow of signals between 
osteocytes and BLCs and also may increase the presence of cytokines or Ca
++
 ions resulting in 
signal reduction.
23
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Moreover, excesive loading and microdamage have been related to higher osteocyte 
apoptosis.
24 36  
Interestingly, computer simulations stated that the inhibitory signal from osteocytes 
are significantly lower when cell apoptosis is present.
25
 Indeed, the greatest reduction in signal is 
when osteocyte apoptosis occurs nearest to the bone surface.
25
 Bone surface is mechanically more 
sensitive than the inner portions of the bone
25, 26
 and therefore apoptosis location is more relevant 
than the total amount of cellular programmed death.
27
 In addition, osteocyte apoptosis is followed 
by an increase release of RANKL in bone leading to osteoclastogenesis and bone resorption.
28, 29
 
Under functional loading conditions, the molecular signals from osteocytes leads to a 
coupling of bone formation and bone resorption, being first increased in higher levels of loading 
and later in lower levels of strain.
16
 A study utilizing a simulation model by finite elements
21
 has 
demonstrated that strain-induced signals from osteocytes guide the osteoclast resorption 
direction,
6
 meanwhile unloading leads to random resorption.
21
 Among other factors, this 
osteoclast guidance is related to the differences in canalicular flow and the levels of nitric oxide 
(NO) in the osteocytes.
6, 30
 
 
 
1.4 Regulation of osteocytes 
Osteocytes maintain an important role during bone formation and resorption and are the 
major source of RANKL in bone,
29
 required for osteoclast differentiation and function.
31
 
Osteocytes also function through Wnt signaling pathways and regulate osteoblast proliferation, 
differentiation and survival.
29, 32
  Wnt has also been suggested to be involved in the induction of 
bone formation even in cases where fibrous encapsulation predominates.
33
 
 
Some pathologies may also influence RANKL expression of osteocytes. For example, the 
presence of estrogens promotes osteocyte viability and reduces cortical bone resorption, but lower 
levels has also been shown to promote osteocyte apoptosis and raise the levels of RANKL.
34
 
Inflammatory mediators such as interleukin –I (IL-1), IL-6 and tumor necrosis-factor (TNF) alpha 
also increase the levels of RANKL and induce osteocyte death.
35
 Finally, PTH basal levels seem 
to maintain bone remodeling by raising RANKL and lowering osteoprotegerin (OPG) release by 
osteocytes.
29
 
 
 
 
 
Page 7 of 38
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 8 
1.5 Bone remodeling around dental implants 
After dental implants are anchored, a sequence of immune-inflammatory responses 
followed by angiogenesis and eventually osteogenesis take place to achieve osseointegration. 
This is influenced by the implant surface characteristics owing to the ability for protein 
adsorption based on implant surface topography and hydrophilicity. Accordingly, thrombin and 
fibrinogen adhere to the implant surface. Later, neutrophils populate the implant recipient site 
before the monocytes and macrophages infiltrate the area. These events fulfill a key role on the 
early homeostasis as they release the cytokines and growth factors that stimulate collagen matrix 
deposition around the titanium oxide layer leading to newly-formed woven bone (usually occurs 
5 days later). In a matter of 8 to 12 weeks, lamellar bone initiates the biological stability, namely 
osseointegration.
1
  
As it occurs with the natural dentition, implants are subjected to soft and hard tissue 
remodeling after restoration delivery. Biologic width in humans around dental implants has 
recently been shown to be ~3.5mm.
36
 This physiological bone remodeling mechanism to a foreign 
body is led by RANKL, which promotes macrophage activation into osteoclasts. When early 
implant marginal bone loss exposes the implant microtexture, contamination by bacterial and its 
byproducts is facilitated and thus, the infiltration of large proportions of CD68- and 
myeloperoxidase (MPO)-positive cells are capable of breaking down the peri-implant structures.
37
 
It has been suggested that the microgap in two-piece implants might be associated with the up 
regulation of the inflammatory cell infiltrate leading to crestal bone loss.
38, 39
 The abutment 
connection on the endosseous portion of the implant leaves a gap in a range of 10- to 50- 
micrometers.
 38
 A pumping effect of the fluid contained in the implant cavities might shift 
inwards to the peri-implant compartment due to the cyclical loading of the implant/abutment 
interface
38 40
 and facilitate the colonization of the gap by putative pathogens. These organic fluids 
with bacteria products and endotoxins could upregulate the expression of pro-inflammatory 
cytokines in the peri-implant tissues and stimulate the chemotaxis of active osteoclasts.
38
 Over the 
time, leakage associated to micromovements leads to steady inflammatory reaction,
41
 bone loss 
around the implant neck and later, in the presence of biofilm, to peri-implantitis.
42
 It seems that 
internal implant connections provide better sealing than the external ones.
42
 
43
  Tesmer et al. 
reported a higher number of colonies former unit (CFU) of Aggregatibacter 
actinomycetemcomitans and Porphyromonas gingivalis in samples of trilobe connection vs. 
morse cone connection in an in vitro study.
44
 Moreover, conical seal systems have been related to 
less crestal bone loss.
43
 Nonetheless, it remains to be elucidated the association of the gap size or 
microbial leakage at the implant-abutment connection with the crestal bone loss.
45
 In addition, it 
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remains controversial the influence of the position of the implant-abutment connection on crestal 
bone loss.
45
 Even though, a greater density of neutrophils have been reported in subcrestal 
interfaces vs. supracrestal location. 
38, 39
 Further improvements on the implant-abutment sealing 
together with encouraging to use the original components might minimize the crestal bone loss 
associated to microgap inflammation. 
 
As aforementioned, peri-implant implant bone undergoes remodeling after surgery 
trauma and due to the biological width establishment, but also it keeps in active bone remodeling 
during years as stimulated by the masticatory loading after the post-implantation healing.
46-48
 In a 
short-term follow-up study in dogs, Gyoon-Kim et al. reported that newly formed bone had lower 
ability to resist elastic, plastic and viscous deformation but higher viscoelastic capacity to absorb 
deformation energy than the old resorbed bone. This fact might explain why bone is able to bear 
the impact of masticatory loading transmitted from the implant in absence of the periodontal 
ligament.
46
 Baldassarri et al. demonstrated that bone only reaches maturity after 5 years of 
loading and an increase of elastic modulus and hardness have been observed during that time in 
human retrieved implants.
47
 Interestingly, a reduction in osteocyte density in samples after long 
period of loading have been reported,
48
 and a possible explanation was the limited number of 
cells needed to maintain bone homeostasis after bone is matured, well aligned and 
biomechanically competent.
48
  In this sense, initial healing process takes up to the first year of 
loading and imply the remodeling of initial woven bone and a high number of osteocytes. The 
second stages comprises up to the fifth year when bone matures after another active remodeling 
period and also a higher presence of osteocytes. Last, the third stage seems to imply a reduction 
in osteocytes numbers and bone remodeling.
48
  
 
2. Excess of implant torque on bone healing 
2.1. Bone biology under implant insertion  
Adequate implant insertion torque (IT) values (25-45 Ncm) have been suggested to 
prevent micro-movement that could lead to fibrous encapsulation. On the flip side, high insertion 
torque has also been associated with an increase in critical pressure triggering microfractures and 
bone necrosis (Figure 3). It has been shown in animal models that high IT elicits a complex 
microdamage being a strong stimulator for initiating targeted bone remodeling. Moreover, it was 
evidenced that cortical bone resorption occurs on the surface of differently oriented Haversian 
and Volkmann canals.
49
 This was in agreement with a radiographic, histomorphometrical and 
histological investigation that clearly identified that implants with a high IT (>50 Ncm) are 
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subject to greater peri-implant bone loss in the early stages of healing compared to those more 
passively placed.
50
 Additionally, a recent multiscale analysis revealed that under drilling to 
achieve high IT, a double layer of dead and dying osteocytes was observed when compared to 
low IT.
51
 Moreover, it was shown that osteocyte lacunar density in human cortical bone is 
associated with micro-cracks accumulation and porosity increase with age.
48 52
 This finding 
highlights the importance of minimizing microfractures as a consequence of high IT to 
predictably preserve the peri-implant bone level. Thereby, it seems highly coherent to state that 
the lack of primary stability may potentially jeopardize osseointegration, high IT might not favor 
the preservation of the peri-implant tissue level.  
 
Finite elements studies have shown that loading increases bone formation and inhibits the 
resorption and that bone disuse promote bone loss,
20
 
21
 so a contradiction between recommending 
low IT levels and may be observed. However, increased IT may lead to osteocyte apoptosis and 
consequently may promote higher levels of RANKL and VEGF secretion to the surrounding 
environment to remove apoptotic cells.
29
 
53
 Higher levels of RANKL has previously been 
reported 100-200 microns away from microcracks and lower levels of OPG were observed up to 
200 microns away from microcracks.
53
 Verborgt et al. reported that viable osteocytes next to 
microdamaged areas promoted cell apoptosis by expressing higher levels of Bax gene and that the 
highest levels of the anti-apoptotic protein Bcl-2 was reached 1-2 mm away from microcracks.
54
 
Moreover, osteoclasts not only remodel disused bone, but also damaged bone like microcracks.
55
 
23
 In this area two stimuli promote osteoclast activation.
21
 First of all, dying osteocytes release 
chemotactil signals to attract osteoclasts and raise RANKL levels. Secondly, osteocyte-dead areas 
do not emit the osteoclast inhibitory signals. These signals might be transmitted preferently 
following the direction where the bone was deposited,
21
 triggering greater peri-implant bone loss 
in the crestal area. 
 
Alveolar bone density further influences primary stability. An early publication in the 
field of implantology classified the maxillary ridges in four major types.
56
 Accordingly, denser 
bone is located in the anterior mandibular region, whereas more porous trabecular bone is 
detected in the posterior maxillary area. Recent findings seem to point to the influence of bone 
atrophy on bone density.
57
 Cortical bone has a higher elastic modulus
58
 and compressive strength 
when compared to cancellous bone.
59
 Nonetheless, it is worth noting that the restrained 
vascularity of compact bone, implying minimal to no migration of differentiating osteogenic 
cells, may result in peri-implant bone loss in the event of trauma. In the same way,  Kristensen et 
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al. reported the three main routes of osteblast recruitment during remodeling: aproximately 20% 
of the osteoblastic cells come from reactivation of BLC on quiescent surfaces, 50% are canopy 
cells from the mesenchymal bone marrow and the last third are vascular-associated 
osteoprogenitors like pericytes that reach the bone remodeling area by the canopies.
60
 Limited 
blood supply and abscence of bone marrow might limit the amount of osteoblast cells in the bone 
remodeling area, and in some cases the area may not reach the critical osteoblastic cell density 
needed for bone formation to occur,
60
 showing an arrested reversal area where only bone 
resorption can take place.
61
 
 
Simons et al. studied the association of the proportion of cancellous/cortical bone on 
marginal bone loss.
62
 The authors identified that higher cancellous proportion (>50-60%), and 
early bone loss was significantly minimized (~0.6-0.7mm) when compared to implant recipient 
sites (<30%) of cancellous content (~1.5mm). Therefore, high IT should be omitted, in particular 
in the presence of a thick cortical layer. In order to avoid microfractures as a consequence of high 
IT, tapping should be advocated. 
 
In summary, cortical bone presents with several disadvantages when compared to 
trabecular bone. The limited bone supply may impair osteoprogenitors presence and the critical 
osteoblastic cell density required for bone repair might not be reached.
60
 Secondly, the crestal 
bone is exposed to the highest strain levels
63
 and correlates with the most mechanically sensitive 
area in bone.
25, 26
 This highest strain levels are located on the area of first contact when two 
differents materials are in contact and one is loaded.
64
 Moreover, osteocyte apoptosis at the 
surface promotes a more potent resorptive signal than found in deeper bone tissues.
25, 26
 Thirdly, 
according to histological reports, the highest density of osteocyte canaliculi are observed at the 
bone surface perpendicular to the loading force,
6
 therefore a greater amount of damage in this 
zone might be occuring. For such reasons, implant placement protocols (including IT) are crucial 
parameters necessitating adequate control according to their bone characteristics. 
 
2.2. Implant outcomes under high and low implant torque 
While the belief behind achieving high primary stability has been the goal for many 
clinicians based on the belief that osseointegration would be better warrantied, current clinical 
research seems to indicate that high implant torque might be pernicious for the peri-implant bone 
level. Certainly, for immediate implant placement with/-out immediate loading, solid primary 
stability is necessary (>32 Ncm). 
65, 66
 Nonetheless, in delayed implant placement, understanding 
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the resorption process of the bundle bone and the establishment of the bone macro-architecture 
and bone density might dictate the drilling sequence and IT.  As such, when implant placement is 
applied under high IT (≥50 Ncm), it has been shown to be more prone to marginal bone loss and 
recession, notably in the presence of a thin buccal bone.
67
 Alike, when compared to even higher 
IT threshold (>70 Ncm), it was evidenced that marginal bone loss was substantially higher.
68
 
Strikingly, an association was found statistically correlated when including all the values (up to 
176 Ncm). This finding further reflects the role that bone structure plays and its influence on the 
fate of the peri-implant bone level.  
For the aforementioned reasons, novel approaches for implant placement are being 
investigated. One example is the use of simplified drilling methods that have not seemed to 
jeopardize the process of osseointegration.
67, 68
 For example, wider implants installed under 
higher IT have shown adequate secondary stability and high bone-to-implant contact (BIC); 
although it was demonstrated that a certain healing delaying was found due to the necrosis of the 
existing bone.
69
 Alike, findings from another group also indicated that even submerged implants 
inserted at 0 Ncm torque displayed similar outcomes compared to those inserted at 30 Ncm or 70 
Ncm at 4 months.
70
 In partial agreement, Campos et al. found that although the BIC was not 
affected, adequate drilling to achieve passive implantation outperformed over-/under-drilling by 
means of the bone area fraction occupied.
71
 Hence, clinical outcomes echo the uncertain impact 
high IT might have on peri-implant bone loss compared to low IT. Future research are currently 
investigating alternative strategies including the application of osseodensification protocols,
72
 
lasers
73
 
74
 or ultrasound tools
75
 
76
 
77
 
78
 to enhance osseointegration.  
 
3. Trauma from occlusion 
Although peri-implantitis and overload in conjunction with the host characteristics may 
be the major etiological agents causing late failures, 
79
 the influence of trauma from occlusion on 
peri-implant disease has not been yet elucidated.
80
 In a systematic review based on animal 
studies, Chambrone et al. reported that occlusal overload may lead to bone loss in the presence of 
dental plaque and to a higher bone density if plaque control is performed.
81
 Heitz-Mayfield et al. 
reported in a dog study that overload did not impact on healthy implants, with no differences in 
BIC.
82
 It is important to highlight also the series of animal studies from Miyata et al., who 
reported that inadequate oral hygiene and trauma from occlusion resulted in peri-implant tissue 
breakdown in monkeys, 
83, 84
 even in the lack of plaque-induced inflammation.
83
 Along these 
lines, a systematic review
85
 reported that supra-occlusal contacts on non-inflamed peri-implant 
bone tissues did not cause bone catabolism, whereas supra-occlusal contacts combined with 
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inflammation significantly increased the plaque-induced bone loss. Accordingly, it was concluded 
that the effect of implant overloading on bone/implant loss in clinically well-integrated implants 
is poorly reported and there is not enough evidence to support a cause-and-effect relationship.
85
 
Moreover, a clinical and radiographic study in Macaca Fascicularis confirmed that overloading 
might trigger the loss of osseointegration 4.5-15.5 months after the overload was commenced in 
the vast majority of implants examined. Interestingly, it was further shown that, although 
excessive marginal bone loss was observed (1.8mm), no implant was lost when plaque was 
disrupted but in the lack of occlusal overloading.
86
 
In summary, cautious conclusions should be done on this topic due to a limited and risk-
biased literature and also due to the fact that most of the knowledge in this field is derived from 
animal experimental studies.  
 
 
4. Factors affecting bone metabolism 
 
4.1 Cholesterol and fatty acids 
 In the last three decades, the consumption of high-fat and high-cholesterol-diets have 
increased
87
 and as a consequence, the morbidity and mortality of obesity-related diseases such as 
cardiovascular disease and hyper-inflamed conditions have also increased.
88, 89
 Obesity has also 
been related with an enhanced hazard of periodontal disease in man.
90, 91
 
 Although obesity and high levels of cholesterol production have been linked for years, the 
relation between obesity and serum levels is low.
92
 
93
 
94
  Similarly, the relationship between bone 
and body fat is complex and not totally understood to now.
95
 Bone marrow fat (BMF) is the 
accumulation of fat cells inside the bone marrow tissue.
96
 An inverse correlation between bone 
mass and BMF has been reported.
95-98
 Higher adipogenesis in BM may result in lower 
osteoblastogenesis and these adipocytes can secrete saturated fatty acids which may impair 
osteoblast viability by inducing apoptosis and autophagy.
96, 97
 Adipocytes can also release pro-
inflammatory and osteoclastogenic cytokines (e.g., TNFα and IL-6), adipokines and express 
RANKL.
95, 96, 98-100
 
 In other words, fatty acids
97
 and high levels of cholesterol
101
 may disturb the bone 
formation/bone resorption equilibrium by down-regulating the Wnt signaling pathway.
102
 This is 
probably due to the effects of higher levels of TNFα and sclerostin.
103
  Wnt pathway balances the 
mesenchymal stem cells differentiation by inhibiting of adipogenesis and promoting osteoblast 
proliferation, maturation and differentiation.
97
 Animal studies have shown more bone resorption, 
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less bone formation and bone mass and higher levels of bone turnover markers after rich-
cholesterol diets.
97
 
101
 
104
 
105
 
106
 
 In addition, obesity induces a systemic inflammation condition with high levels of 
circulating cytokines and increased production of monocytes, neutrophils
107, 108
 and adipose tissue 
macrophages.
109, 110
 These cytokines and the accumulation of cholesterol in macrophages can alter 
the ratio of M1/M2 macrophages promoting an M1 pro-inflammatory environment thereby 
increasing the numbers of monocytes/macrophages in circulation.
109, 111 
The influence of obesity and increased levels of cholesterol and triglycerides have been 
extensively described in the medical field but the effect of hyperlipidemia on dental implant 
osseointegration has not yet been fully elucidated.
112
  Significantly more peri-implant bone loss, 
reduced bone formation and lower strength in the bone-implant interface has previously been 
reported in mice after a 12 week high-fat diet.
112
 On the other hand, Dündar et al. (2016) reported 
that there was no difference in BIC 12 weeks after implant placement between rabbits following a 
3-month high-fat diet versus normal diet.
113
 As hyperlipidemia might impair bone quantity and 
density, negative effects might be speculated on implant osseointegration although no conclusive 
evidence to date has been found. 
 
4.2 Vitamin D 
Vitamin D is a fat-soluble hormone that regulates calcium phosphate homeostasis and 
mineral bone metabolism.
114
 It is transformed into the active form (1,25-dyhydroxy vitamin D3) 
by hydroxylation, firstly in the liver and then in the kidney.
115
 This vitamin can stimulate 
osteoblast bone matrix production, coupling bone resorption to formation and optimize bone 
remodeling.
116
 It increases calcium absorption in the intestine leading to a reduction in PTH 
secretion and lower systemic bone resorption
115, 117, 118
 with a possible inhibition of 
osteoclastogenesis.
119
 1,25-dyhydroxy vitamin D3 can stimulate bone resorption by binding to 
osteoblast vitamin D receptors (VDR) and by altering the balance between RANKL and OPG.
120-
123
 
Vitamin D is a common substance in the prevention and treatment of osteoporosis but 
research investigating its effects during dental implant osseointegration remains limited.
118
 In 
animals, Kelly et al. (2009) studied the osseointegration process in rats with deficiency in 
Vitamin D and reported lower BIC values and mechanical bone strength after 2 weeks post-
implant placement.
124
 Noteworthy however is that implant failure might be confounded by the 
rising insufficiency of vitamin D prevalence in various patient populations.
124
 Zhou et al. (2012) 
reported an improved titanium screw fixation in ovariectomized rats after 8 weeks of oral 
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treatment with vitamin D, showing a significant increment of peri-implant bone density, bone-
implant contact (1.5 times higher) and peri-implant trabecular microarchitecture.
118
 Similar 
results were reported in mice with chronic kidney disease (CKD), suggesting that vitamin D 
treatment may be an effective approach for implant placement in patients with CKD.
125
 Recently, 
the effect of topical application of vitamin D (10%)
126
  and melatonin (5%)
127
 solutions on the 
surface of immediate implants placed in dogs was evaluated. Both topical applications improved 
significantly new bone formation around implants and reduced crestal bone loss at 12 weeks 
following surgery, 
127
 standing out the positive correlation between vitamin D and early stages of 
osseointegration. Therefore, these results may suggest that vitamin D has a protective effect on 
bone healing after implant insertion.
118
  
Schulze-Spate et al. (2016), in a randomized, double-blind, placebo-controlled clinical 
trial in humans, reported no differences in bone formation nor in graft resorption after maxillary 
sinus augmentation procedure with vitamin D and calcium supplement.
123
 Only a difference in the 
number of bone-resorbing osteoclasts was assessed, finding a higher bone remodeling activity 
related to higher vitamin D levels.
123
 A retrospective study to correlate early implant failure and 
low serum levels of vitamin D
128
 showed a higher incidence of the implant failure rate in these 
patients but a correlation between both factors could not be determined. Therefore, vitamin D 
seems to improve bone health and implant healing but further research is needed to obtain an 
adequate level of evidence. 
 
 
4.3 Hyperglycemia 
The number of adults with diabetes in the world increased from 108 million in 1980 to 
422 million in 2014.
129
 Type 1 diabetes (previously known as insulin-dependent, juvenile or 
childhood-onset) is characterized by deficient insulin production and requires daily administration 
of insulin. Type 2 diabetes (formerly called non-insulin-dependent or adult-onset) results from the 
body’s ineffective use of insulin. Type 2 diabetes comprises the majority of people with diabetes 
around the world and is largely the result of excess body weight and physical inactivity. It is 
characterized by hyperglycemia, insulin resistance and relative insulin deficiency.
130
 
Diabetes mellitus has been related to a deficient metabolism of the skeletal tissue due to a 
supressed osteoblastic function and lower bone formation potential, independently of the type of 
bone, the location and mechanical loading.
131
 A higher risk of implant failures have been related 
to uncontrolled diabetes
132
 and non-diagnosed diabetes might be a possible reason of failed 
implants for unknown reasons.
133
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Ajami et al. reported a delayed bone formation and remodeling in hyperglycemic rats. 
Early bone mineralization might be affected due to a compromised intra-fibrillar collagen 
mineralization whereas inter-fibrillar and cement line mineralization remained normal.
134
 Other 
mechanism could be the fact that diabetes promotes a hypercogulative state and a delay in fibrin 
clot resolution due to an increased thrombin formation, platelet activation and fibrin resistance.
133
 
135
 These facts hinder platelet cytokines and growth factor release and cause a limited pericytes 
and endothelial migration into the implant surface together with a reduced angiogenesis.
136
 
Moreover, hyperglycemic conditions are related to a reduction in bone formation markers like 
osteocalcin and bone-specific alkaline phosphatase and also bone resorption markers like C-
terminal telopeptide of collagentype I (CTX).
137
 Serum levels of osteoprotegerin (OPG) are 
increased following an episode of hyperglycemia and it also leads to a lower bone density due to 
the accumulation of advanced glycation end products (AGEs) that affect the organic bone matrix, 
reduce osteoblast proliferation and function and increase osteoclast resorption.
137
 
138, 139
  
Moraschini et al. concluded in a systematic review that the rate of implant failure is not 
higher for diabetic subjects than non-diabetic ones, nor between type 1 and type 2 diabetic 
subjects.
140
 However, non-diabetic patients showed a statistically significant less crestal bone loss 
than diabetic patients.
140
 Furhter studies are needed to elucidate the impact of hyperglycemia 
upon dental implants. 
 
 
4.4 Other factors 
Not only metabolic issues can influence bone remodeling. Some patient-specific factors 
like medication intake might induce changes in bone cells and bone turnover and lead to bone 
loss around dental implants.
141
 Higher bone turnover seems to expose more implant surface
140
 and 
mandible might be a particularly vulnerable location.
141
 Serotonin reuptake inhibitors and proton 
pump inhibitors have been related to an increase in bone loss and higher implant failure
142
.  so an 
updated and thorough medical records are advocated to avoid complications.  
Other patients might present some degree of hypersensivity to titanium particles
143
 or 
ions released from implant surface.
141
 The corrosion of the implant surface or the dioxide layer 
titanium degration can release  particles that induce inflammatory reactions in the peri-implant 
tissues.
144
 Aseptic loosening is the main reason for implant hip long-term failures.
145
 According 
this model, wear particles are recognized as foreign body substances and phagocytosed by 
macrophages.
144
 Later, M1 cells release inflammatory cytokines that promote osteoclastogenesis 
and osteolysis of the peri-implant bone.
144
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5.  Role of macrophages in bone and peri-implant breakdown and regeneration 
Macrophages play a prominent and central role in bone homeostasis and bone/biomaterial 
integration around dental implants.
146
 Specifically in bone tissues, a special subset of 
macrophages, termed osteal macrophages (or OsteoMacs), have recently been hypothesized to 
play a pivotal role in the fate of implant osseointegration.
146
 The general role of OsteoMacs in 
bone is to act as immune surveillance cells within their microenvironment.
147, 148
 Yet when a 
foreign body biomaterial such as a dental implant is inserted trans-mucosally into the alveolar 
bone, a rapid accumulation of macrophages is typically found at the implant surface.
149
 Chehroudi 
et al. clearly showed that bone formation on rough titanium dental implant surfaces was routinely 
preceded by macrophage accumulation (prior to bone deposition).
149
 Despite this prominent 
finding, it is interesting to note that over 90% of research to date has focused on osteoblast and 
fibroblast behavior to material surfaces with only a small percentage (10%) dedicated to immune 
cell interactions including monocytes, macrophages, osteoclasts, leukocytes and multinucleated 
giant cells (MNGCs).
150
 This major discrepancy is difficult to understand given the fact that 
macrophages and immune cells in general dictate how biomaterials will eventually be integrated 
into host tissues. 
 Studies from basic research have been pivotal to better understand the role of 
macrophages in bone biology. A series of key studies on OsteoMacs has shown that their removal 
during bone development is consistently found associated with a reduction in bone modeling, 
bone remodeling and bone repair.
151-154
 Furthermore, in primary osteoblast cultures (containing 
macrophages), the simple removal of macrophages from these in vitro systems leads to a 23-fold 
decrease in the mineralization potential of bone-cells.
153, 155
 Therefore, while basic studies have 
clearly pointed to their vast and substantial role in bone biology, much less information is 
available concerning the response of macrophages to implanted biomaterials. It is therefore 
pivotal to better characterize how immune cells and macrophages behave in relation to dental 
implant osseointegration and maintenance. 
5.1. Macrophage polarization: M1-M2 phenotypes 
While the objective of this review is not to highlight macrophage biology, it is important 
to note that they are some of the most plastic cell types found in the human body. They polarize 
completely from the classical M1 macrophage (involved in tissue pro-inflammation) towards M2 
(tissue regeneration) macrophages. They may also fuse into osteoclasts and resorb bone or fuse 
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into multinucleated giant cells (MNGCs) where their role remains poorly defined.
156, 157
 Major 
differences between M1 and M2 macrophages is that M1 macrophages have their arginine 
metabolism shifted to nitric oxide (NO) and citrulline, whereas M2 macrophages are shifted 
towards ornithine and polyamines.
158
 M1-macrophages produce NO as a main effector molecule 
capable of inhibiting cell proliferation,
159
 while M2-macrophages generate ornithine increasing 
cell proliferation and repair through polyamine and collagen synthesis.
160
 
During dental implant osseointegration, classical M1-macrophages secrete a wide array 
of pro-inflammatory cytokines including TNF-alpha, IL-1Beta, IL-6, Il-12, MMP2, MMP9 
typically induced by IFN-γ + LPS or TNF-α (in vitro).
159, 161
 In contrast, M2-macrophages are 
produced in response to IL-4 or IL-13 and also secrete a wide variety of pro-regenerative 
cytokines including PDGF-BB, TGB1, VEGF, IL-4, IL-10, CCL18  (Table 1). As can be 
expected, their polarization around implant surfaces is highly relevant for implant integration and 
long-term stability. Interestingly, Spiller et al. showed that macrophages can completely polarize 
from M2 wound-healing macrophages towards M1 pro-inflammatory macrophages within as little 
as 3 days and vice versa.
162
 Therefore, their role, especially as it relates to peri-implant infection, 
is extremely vital for the long-term maintenance of dental implants. 
 
5.2 Impact of implant surface topography and chemistry on macrophage behavior 
 
As previously mentioned, one area of research that has been largely omitted is the effect 
of implant surface material, topography, chemistry and composition on immune cell behavior. 
While this topic has recently been reviewed,
146
 it is important to note that surface roughness in 
general tends to increase a pro-inflammatory response. It has been shown that roughness [e.g., 
sandblasted acid etched (SLA)] surfaces tends to increase M1 macrophage polarization,
163-165
 
whereas a modification to their surface chemistry has been shown to reduce this pro-
inflammatory response (modified-SLA surfaces).
164, 165
 Despite this, a great deal of information 
concerning the behavior of monocytes/macrophages as well as their fusion to MNGCs remains 
unknown. A small percentage of dental implants are lost every year for yet known reasons 
unassociated with peri-implant infections.
146, 166
 This is most likely caused by immune cell 
biocompatibility interactions not yet fully understood and future research in this field is likely to 
further advance of understanding of the prominent role of immune cells during early and late 
stages of implant osseointegration. 
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5.3 Macrophages, Immune Cells and the Foreign Body Reaction 
It has been reported that implant osseointegration is a long-term equilibrium between host 
immune cells and bone biomaterials.
167-169
 The literature showed MNGC accumulation on implant 
surfaces leads to biomaterial breakdown and possible implant failure/rejection.
167-169
  These 
papers provide a platform whereby implant osseointegration and eventual peri-implant bone loss 
is likely a direct result of a M1/M2 shift in macrophage polarization. Interestingly, invading 
periodontal pathogens are known to secrete lipopolysaccharides (LPS), a known and direct 
molecule influencing pro-inflammatory M1-macrophage polarization.
170
 Hence, it is important to 
examine foreign body reaction, equilibrium between M1 and M2 macrophage and MNGC 
polarization. Furthermore, these papers stressed heavily on material rejection with MNGCs 
accumulation on the implant surface. While MNGCs have certainly been implicated in bone 
biomaterial material rejection,
167-169
 it is interesting to note that accumulating evidence has now 
shown that MNGCs (which are hypothetically derived from the fusion of macrophages) are also 
capable of polarizing towards M1-MNGCs and M2-MNGCs. In addition, other researchers have 
shown that MNGCs are capable of expression M2-macrophage markers following macrophage 
accumulation on their biomaterial surface.
171
 Specifically around bone grafting materials, 
MNGCs have been shown to exist in stable human bone many years following their 
implantation
172-174
 and have been associated with a rapid increase in tissue vascularization.
175-178
 It 
is evident that much further research is needed to better understand their role in bone biomaterial 
integration and implant osseointegration. 
It is therefore a necessity to accurately characterize immune cells such as macrophages 
and MNGCs and their interaction with dental implants, their osseointegration and their 
maintenance. It is likely that both cells are prone to reversibly shifting their polarization from 
M1/M2 macrophage/MGNCs yet little research to date has been performed as it relates to dental 
implants. Furthermore, many cell types are found in small spaces within the oral cavity around 
dental implants including osteoblasts, osteoclasts, osteocytes, fibroblasts, endothelial cells, 
leukocytes etc. Since macrophages (and most likely MNGCs) express high levels of cytokines, it 
becomes highly relevant to determine how cell-cell communication occurs between 
macrophages/MNGCs and other cell types (via direct cell contact or paracrine activity) during 
bone remodeling of implants. This field of study has thus far been left entirely unstudied yet 
possesses major clinical implications. 
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It is also interesting to note that more recent research from the field of cardiovascular 
disease has shown that the calcification of arteries is a direct result of macrophages and MNGC 
polarization towards M2-macrophage/M2-MNGCs in the intima layers of arterial walls where 
they express high levels of IFN-gamma.
179, 180
 It has been shown that macrophages polarize 
towards M2 phenotypes and begin to form ectopic bone in areas where bone should otherwise not 
be formed.
146
 Hence, it is interesting to point out that in this scenario, immune cells (such as 
macrophages) are dictating new bone formation. Therefore, growing evidence from many fields 
has now shown that macrophages playing a vast and substantial role in bone modeling and 
homeostasis.  
Conclusions 
The present review highlights some of the recent advancements in the area of bone remodeling 
around dental implants in both health and disease conditions. While peri-implant bone 
remodeling has received much attention, it remains important to better understand how loading 
and implant bed preparation affects bone lining cells and osteocyte viability and signaling at early 
stages of healing. Furthermore, the effects of systemic levels of cholesterol, fatty acids and 
vitamin D are discussed as potential responsible factors for early implant loss and long-term 
implant stability. We also stress out the prominent role of immune cells (e.g., OsteoMacs and 
multinucleated giant cells) and their impact during dental implant osseointegration and 
maintenance.  
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Figures and legends. 
 
Table 1. Cytokines released by M1 and M2 macrophages. 
Figure 1. Histological section of maxillary sinus lateral wall with cortical bone surface covered 
by bone lining cells (Immunofluorescence for Tubulin and DAPI, 20x). 
 
Figure 2.  Bone remodeling diagram. A; Cells involved in the process (modified from 
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011). Cancer to bone: a fatal 
attraction. Nature Reviews Cancer, 11(6), 411-425. B; Bone remodeling after excessive implant 
torque. 1) Excesive torque promotes bone damage including the osteocyte network. 2) 
Osteoblasts and osteoclasts are recruited from the blood, the marrow or from BLCs to populate 
the bone remodeling compartment. 3) Osteoclasts remove the damaged bone. 4) Bone lining cells 
clean the debris after osteoclast resorption. 5) BLCs secrete fibrillar collagen. 6) This collagen 
layer  allows osteoblasts to attach. 7) Osteoblasts deposit osteoid to fill the compartment. 8) 
Osteoblasts trapped into the osteoid become osteocytes or bone lining cells where most undergo 
apoptosis (modified from Seeman E. Bone modeling and remodeling. Crit Rev Eukaryot Gene 
Expr 2009; 19: 219-233). 
 
Figure 3. Bone microcracks as a consequence of excesive implant torque (modified from Cha JY, 
Pereira MD, Smith AA, Houschyar KS, Yin X, Mouraret S, Brunski JB, Helms JA. Multiscale 
analyses of the bone-implant interface. J Dent Res 2015; 94: 482-490. 
Upper images (A, B, C) : Schematic of the osteotomy relative to the implant’s external diameter. 
Image A shows an oversized preparation with the presence of a gap (*) between the implant and 
bone. This gap is filled with fibrous tissue. Image B shows a osteotomy where the implant 
reached low torque and a smaller gap (*) is observed. Image C shows an undersized osteotomy 
that induces a high torque without gap bone-implant.  
Image D: Illustration of compressive strain fields around an implant placed with low torque. Only 
15-20 microns of the thread engaged in bone and promoted a small region of moderate strain. 
Image E: Illustration of increased compresive strain fields around an implant placed under 
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increased torque. The threads engaged deeply in bone and created a larger region of high strain 
around the threads and the implant body. Image F: Illustration of photoelastic stress around an 
high-torque implant. 
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Figure 1. Histological section of maxillary sinus lateral wall with cortical bone surface covered by bone lining 
cells (Immunofluorescence for Tubulin and DAPI, 20x).  
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Figure 2.  Bone remodeling diagram. A; Cells involved in the process (modified from Weilbaecher, K. N., 
Guise, T. A., & McCauley, L. K. (2011). Cancer to bone: a fatal attraction. Nature Reviews Cancer, 11(6), 
411-425. B; Bone remodeling after excessive implant torque. 1) Excesive torque promotes bone damage 
including the osteocyte network. 2) Osteoblasts and osteoclasts are recruited from the blood, the marrow or 
from BLCs to populate the bone remodeling compartment. 3) Osteoclasts remove the damaged bone. 4) 
Bone lining cells clean the debris after osteoclast resorption. 5) BLCs secrete fibrillar collagen. 6) This 
collagen layer  allows osteoblasts to attach. 7) Osteoblasts deposit osteoid to fill the compartment. 8) 
Osteoblasts trapped into the osteoid become osteocytes or bone lining cells where most undergo apoptosis 
(modified from Seeman E. Bone modeling and remodeling. Crit Rev Eukaryot Gene Expr 2009; 19: 219-
233).  
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Figure 3. Bone microcracks as a consequence of excesive implant torque (modified from Cha JY, Pereira MD, 
Smith AA, Houschyar KS, Yin X, Mouraret S, Brunski JB, Helms JA. Multiscale analyses of the bone-implant 
interface. J Dent Res 2015; 94: 482-490.  
Upper images (A, B, C) : Schematic of the osteotomy relative to the implant’s external diameter. Image A 
shows an oversized preparation with the presence of a gap (*) between the implant and bone. This gap is 
filled with fibrous tissue. Image B shows a osteotomy where the implant reached low torque and a smaller 
gap (*) is observed. Image C shows an undersized osteotomy that induces a high torque without gap bone-
implant.  
Image D: Illustration of compressive strain fields around an implant placed with low torque. Only 15-20 
microns of the thread engaged in bone and promoted a small region of moderate strain. Image E: 
Illustration of increased compresive strain fields around an implant placed under increased torque. The 
threads engaged deeply in bone and created a larger region of high strain around the threads and the 
implant body. Image F: Illustration of photoelastic stress around an high-torque implant.  
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Table 1: Markers of macrophages of M1 and M2 phenotypes, adapted from 
136
. Those 
highlighted in yellow are most common markers utilized to investigate M1 and M2 
macrophage polarization. 
 
 
M1 M2 
В 7 (CD80) M130 (CD163) 
В7.2 (CD86) CD206 (MRC1, mannose receptor) 
CCR7 (МСР-3) FceRII (CD23) 
CCL22 (MDC1) 
CD64 
CD36 
CXCL10 (IP-10) 
SOCS1 
IL-1 Ra 
TLR-2 Nucleotide receptors (GPR86, GPR105, 
TLR-4 P2Y8, P2Y11, P2Y12) 
FcyRIII (CD16) С-type lectin-like receptor dectin-1 
FcyRII (CD32) DC-SIGN (CD209) 
LAM-1 (CD62) DCIR (CLECSF6) 
IL-1 R1 CLACSF13 
IL-7R (CD127) FIZZ1, ST2 (mouse) 
IL-2R (α chain) Phagocyte receptors (SR-A, М60) 
IL-15R (α chain) CXCR4, fusin (CD184) 
IL-17R (CTLA8) (CDw217) TRAIL 
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